Purchase Order 75N93025P00985
Award Date
5/25/25
Potential Completion Date
5/24/26
Potential Value
$62K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hamilton, MT 59840, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $93,525.44 contract provides a 12-month silver support plan for two NextSeq 2000 sequencing systems. No set-aside was used. Illumina is a manufacturer and provider of genomic analysis instruments and reagents, and has previously received prime federal contracts and sub-awards from the NIH, CDC,...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $48,209 firm fixed price purchase order to Illumina, Inc. to provide two Nextseq 2000 Silver Support Plans. The solicitation sought comparable services to support NIAID's genomic research efforts, including full parts, labor, and travel coverage; reagent replacement for hardware failures; remote and on-site technical support; software and...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for a NextSeq 2000 Silver Support Plan and Preventive Maintenance with a total ceiling value of $23,717.81. The award does not utilize any set-aside designations. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has received prior prime federal contract and sub-grant awards...
This is a one-year, $48,209 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a renewal service agreement on an Illumina NextSeq 2000 genomic sequencing instrument used for research, diagnostics, and developing personalized medicine. The award is a sole-source contract for comprehensive maintenance and support services, including full coverage for parts,...
This is a firm fixed-price purchase order valued at $30,221.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the annual renewal of the NexSeq Silver Support Plan, which provides maintenance and technical support services for Illumina's DNA sequencing instruments. Illumina is a leading manufacturer of genetic analysis equipment and has been awarded numerous prior federal...
This is a $41,061.69 firm fixed-price purchase order awarded to Illumina, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) for a NEXTSEQ 500 and MISEQ service agreement. The contract has a period of performance through February 27, 2025. Illumina is a manufacturer of genetic sequencing instruments and reagents that has previously provided similar products and services to support genomic research and diagnostics across various federal agencies. This award does not...
This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc. for approximately $140,000. The contract is for service agreements to provide preventative maintenance, technical support, software and hardware updates for multiple Illumina DNA sequencers located at the NIH Vaccine Research Center in Bethesda, Maryland, over a one year period of performance from...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for an Illumina Service Contract. The contract has a ceiling value of $72,973.00 and a period of performance through February 28, 2026. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, will provide maintenance and support services for NIAID's Illumina sequencing systems, including NextSeq,...